In the article entitled "Ingestion of hyaluronans (molecular weights 800 k and 300 k) improves dry skin conditions: a randomized, double blind, controlled study" by Kawada *et al.* (*Journal of Clinical Biochemistry and Nutrition* 2015; **56**: 66--73), several errors in Fig. [3](#F3){ref-type="fig"} and Table [2](#T2){ref-type="table"} and [5](#T5){ref-type="table"} have been identified. Fig. [3](#F3){ref-type="fig"}A showed lines of the HA 800k group and the HA 300k group inversely, and legend of Fig. [3](#F3){ref-type="fig"} showed Dunnett's test instead of Steel Dwass test as statistical analysis. Table [2](#T2){ref-type="table"} and [5](#T5){ref-type="table"} showed several erroneous values and missing information: i.e., Table [2](#T2){ref-type="table"} should be showed unit information, and max. and min. amplitude value of Table [5](#T5){ref-type="table"} should be showed standard errors multiplied by 10^−1^. Corrected sentences, figure and tables are printed below.

p\. 69, line 3

Furthermore, the significant improvement in skin luster was maintained in [the HA 800 k group]{.ul} 2 weeks after consumption ended (*p*\<0.05).

![Changes in the subjective skin condition with time following ingestion of hyaluronans and placebo. The subjective skin conditions, i.e., luster, suppleness, and wrinkles, were evaluated using a questionnaire prior to ingestion, 3 and 6 weeks of ingestion, and 2 weeks after ingestion ended. Differences in each questionnaire result relative to the baseline condition (⊿): (A) luster, (B) suppleness, and (C) wrinkles. ![](jcbn14-81f01_cap1.jpg) indicates the placebo group; ![](jcbn14-81f01_cap2.jpg) indicates the HA 800k group; ![](jcbn14-81f01_cap3.jpg) indicates the HA 300k group. Steel Dwass test was used to compare the three groups. Data are present as means ± S.E. ^†^*p*\<0.10 and \**p*\<0.05.](jcbn14-81f03){#F3}

###### 

Baseline characteristics of the study subjects

                                          Placebo                 HA 800k                 HA 300k                 Total
  --------------------------------------- ----------------------- ----------------------- ----------------------- --------------
  Number of subjects                      22                      19                      20                      61
  Mean age (Age Range)                    42.73 ± 0.92 (35--60)   43.68 ± 1.23 (35--60)   43.90 ± 1.06 (35--60)   43.41 ± 0.61
  Sex                                                             female                                          
  Skin moisture (stratum corneum; a.u.)   19.49 ± 1.85            19.31 ± 1.78            21.53 ± 1.61            20.10 ± 0.96
  Skin viscoelasticity                                                                                            
   Max. amplitude (mm)                    0.32 ± 0.01             0.35 ± 0.01             0.32 ± 0.01             0.33 ± 0.01
   Min. amplitude (mm)                    0.08 ± 0.01             0.09 ± 0.01             0.09 ± 0.01             0.09 ± 0.00
  Return rate (%)                         73.84 ± 1.76            73.86 ± 1.21            72.74 ± 1.50            73.48 ± 0.88

###### 

Changes in skin viscoelasticity following ingestion of hyaluronans and the placebo

  Skin viscoelasticity                   Prior to ingestion   3 weeks of ingestion   6 weeks of ingestion   2 weeks after ingestion ended
  ---------------------------- --------- -------------------- ---------------------- ---------------------- -------------------------------
  Max. amplitude (10^−1^ mm)   Placebo   3.02 ± 0.11          2.33 ± 0.11\*          3.00 ± 0.13            3.19 ± 0.13
                               HA 800k   3.15 ± 0.14          2.51 ± 0.16\*\*\*      2.88 ± 0.18            3.21 ± 0.18
                               HA 300k   3.23 ± 0.11          2.52 ± 0.14\*\*\*      3.08 ± 0.16            3.45 ± 0.13
  Min. amplitude (10^−1^ mm)   Placebo   0.71 ± 0.05          0.24 ± 0.04\*\*        0.58 ± 0.04\*          0.66 ± 0.04
                               HA 800k   0.72 ± 0.05          0.24 ± 0.02\*\*\*      0.66 ± 0.05            0.70 ± 0.07
                               HA 300k   0.81 ± 0.05          0.23 ± 0.03\*\*\*      0.68 ± 0.04\*\*        0.74 ± 0.04
  Return rate (%)              Placebo   76.44 ± 1.57         89.75 ± 1.32\*\*\*     80.12 ± 1.51\*         79.00 ± 1.53
                               HA 800k   76.37 ± 1.81         89.94 ± 0.94\*\*\*     76.45 ± 1.66           77.05 ± 2.36
                               HA 300k   74.11 ± 1.57         90.46 ± 1.10\*\*\*     77.08 ± 1.66           77.70 ± 1.72

\**p*\<0.05, \*\**p*\<0.01, and \*\*\**p*\<0.001 vs prior to ingestion according to a paired *t* test. Means ± SE. HA, hyaluronan.
